Crispr Therapeutics shares tumble after significant earnings miss
Kevin Rayment, Vice President and COO of Curtiss-Wright Corp (NYSE:CW), which has seen an impressive 55.7% return over the past year according to InvestingPro data, recently executed a series of stock transactions. On February 4, Rayment acquired 6,934 shares of common stock through a performance share grant, valued at approximately $2,389,248, based on the closing price of $344.57 per share. The following day, February 5, he sold 2,664 shares at a price of $346.92 each, totaling $924,194. These sales were made in line with the company’s share ownership guidelines to cover tax obligations related to the vesting of the award. After these transactions, Rayment holds 24,236 shares directly.
In other recent news, Curtiss-Wright Corporation has been active in financial and business developments. The company announced a quarterly dividend of $0.21 per share, reflecting its commitment to delivering shareholder value. Additionally, Curtiss-Wright has secured a $27 million contract to supply the U.S. Navy with its Aircraft Ship Integrated Securing and Traversing systems. This contract is part of a larger agreement that could be worth close to $100 million.
Curtiss-Wright also received a positive outlook from Citi, which initiated coverage with a Buy rating. Citi’s analysis suggests potential revenue boosts from defense spending trends and anticipates the company becoming net cash positive by 2026.
Furthermore, Curtiss-Wright has acquired Ultra Energy for $200 million, a move expected to enhance its global commercial nuclear portfolio. This acquisition aligns with the company’s strategic priorities to expand its measurement and control solutions.
Lastly, Curtiss-Wright has announced an expansion of its share repurchase program by $100 million, a decision that reflects the company’s confidence in its financial position and commitment to enhancing shareholder value. These are the latest developments in Curtiss-Wright’s business activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.